COMP <GO>
CPIX vs MRK // FORWARD P/E MULTIPLE
Cumberland Pharmaceuticals Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: CPIX 3
— MRK 7
■ METRIC PARITY
LAST: $4.69 (+7.82%) • MKT CAP: $65.2M
forward-pe
—
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
forward-pe
18.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPIX VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPIX | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 85.00% | 74.80% | +10.20 | CPIX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -16.40% | 20.70% | -37.10 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.42% | 3.42% | +4.00 | CPIX | /fcf-yield <GO> |
| Operating Margin | -6.30% | 34.30% | -40.60 | MRK | /operating-margins <GO> |
| Net Profit Margin | -6.40% | 28.10% | -34.50 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 17.60% | 1.30% | +16.30 | CPIX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.72 | 5.19 | -4.47 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.3 | 51.7 | -16.45 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $65.2M | $361.02B | -$360.96B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPIX REV | MRK REV | CPIX GROSS % | MRK GROSS % | CPIX FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.5M | $65.01B | 85.0% | 74.8% | $4.8M | $12.36B |
| FY 2024 | $37.9M | $64.17B | 82.6% | 76.3% | -$678.6K | $18.10B |
| FY 2023 | $39.6M | $60.12B | — | — | $6.1M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPIX // BETA —
MRK // BETA 0.92